Barely Significant
← all excerpts

Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors.

J Neuroendocrinol · 2025 · PMC11919479 · PMID 40064181

Europe PMCDOI
1
hedged sentence
0.0680
closest p · 1.4× alpha
0.0680
boldest claim

The sentences

nearly significantp < 0.068so close (0.05 < p ≤ 0.1)
In the group with PR, the Karnofsky Performance Status showed nearly significant improvement from 62.5 ± 17 to 80 ± 8 ( p < 0.068), as well as in patients with SD, where a significant improvement in the Karnofsky Performance Status from 66.9 ± 10.4 to 78.5 ± 9.4 ( p < 0.002) was shown.

also in 3,287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.